E. Oostveen (Antwerpen-Edegem, Belgium), A. Houtkooper (Den Helder, Netherlands)
Evaluation of the Oxycon Mobile metabolic system against the Oxycon Pro during rest and cycle ergometry in healthy subjects M. Akkermans, M. Sillen, E. Wouters, M. Spruit (Horn, Netherlands)
| |
Validation of inspiratory capacity and oxygen uptake during exercise breathing heliox H. Groepenhoff, B. G. Boerrigter, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Validation of exercise testing with supplemental oxygen through biological quality control K. De Soomer, R. Heyndrickx, K. Leemans, H. Vaerenberg, W. De Backer, E. Oostveen (Antwerp, Belgium)
| |
Height estimation from arm span: Is the suggested ATS/ERS formula suitable for all populations? L. Lihatchi, C. Tudose, D. Bumbacea, D. Ionita (Bucharest, Romania)
| |
Huff and puff; repeatability of serial home PEF & FEV1 recording in a pharmaceutical trial A. Harrison, E. Watson (Wallingford, Maids Moreton, United Kingdom)
| |
Spirometry quality control in a research centre – Does the quality depend on the pattern of spirometry? D. Ionita, D. Bumbacea, C. Tudose, A. Croitoru, C. Cocian, L. Lihatchi, S. Dumitrache Rujinski, C. Toma, M. A. Bogdan (Bucharest, Romania)
| |
Diffusion capacity quality control in a research centre – Does the quality depend on the spirometry pattern? D. Ionita, D. Bumbacea, C. Tudose, A. Croitoru, C. Cocian, L. Lihatchi, S. Dumitrache Rujinski, C. Toma, M. A. Bogdan (Bucharest, Romania)
| |
Quality of diffusion measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema J. Reinstaedtler, E. Eule, T. Souren (Hoechberg, Germany; Basel, Switzerland)
| |
Quality of forced spirometry in a worldwide multicenter clinical trial with moderate to severe COPD patients with emphysema J. Reinstaedtler, C. Martin, S. Schindelmann (Hoechberg, Germany; Basel, Switzerland)
| |
Quality of forced spirometry in primary care: Effects of the e-Spir@p e-collaboration program F. Burgos, M. L. Garcia, M. L. Rivera, R. Hervas, J. Roca (Barcelona, Badalona, Spain)
| |
Midflows do not vary independently of FEV1 and FVC P. Jak, P. E. Postmus (Amsterdam, Netherlands)
| |
The accuracy of FEF25-75/FVC for primary classification of pulmonary function test M. Mirsadraee, A. Asna-ashari, D. Attaran (Islamic Republic Of Iran)
| |
Spirometric mid-flow measured at six seconds is equivalent to FEV1 for identifying a bronchodilator response M. P. Swanney, J. Dummer, C. O‘Dea, C. Frampton, J. Stanton, P. Kelly, L. Beckert, M. Epton (Christchurch, New Zealand)
| |
FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment R. Boksem, R. Lindeboom, J. W. van den Berg (Zwolle, Amsterdam, Netherlands)
| |
Quality of Helium dilution lung volume measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema J. Reinstaedtler, T. Ochi Lohmann, T. Souren (Hoechberg, Germany; Basel, Switzerland)
| |
Feasibility of conducting a COPD prevalence study using local field workers J. Londhe, B. Brashier, S. Hirve, S. Juvekar, S. Salvi (Pune, India)
| |
Improving quality in spirometry D. Balbuzan, F. Cojocaru, D. Pascal, M. Banica, I. Giurca, D. Ionita (Bucharest, Romania)
| |